Messenger Ribonucleic Acid (mRNA) vaccines gained global recognition during the Coronavirus Disease 2019 (COVID-19) pandemic, proving their value through rapid development, high efficacy ...

In the early days of the COVID-19 pandemic, Moderna (NASDAQ: MRNA) was a top performer, from both a share-price and an earnings perspective. As one of the leading coronavirus vaccine companies ...

People were denied potentially life-saving medicine and instead forced to take experimental mRNA vaccines ... for how many proteins were produced per strand and how accurate the final protein ...

mRNA vaccines achieved their first success against COVID-19, but could a bigger target be next? Ben Hargreaves examines whether the technology could provide a new tool against cancer, and how ...

CureVac and partner GSK are, meanwhile, also developing an mRNA-based flu vaccine, but are a little further back in development, as their shot is in phase 1 testing.

With Louise Bagnall (“Late Afternoon”) at the helm and produced by the Oscar-nominated Cartoon Saloon (“The Breadwinner,” “Wolfwalkers”), this coming-of-age tale mixes whimsy and depth ...

The technology behind Moderna’s COVID-19 vaccine — mRNA packaged in lipid nanoparticles — has the potential to reduce disparities in global health and help fight future pandemics.

WARSAW, Poland, April 16, 2025 — Researchers from the International Institute of Molecular and Cell Biology in Warsaw (IIMCB) described a new mechanism that improves the efficiency of mRNA-based ...

This advertisement has not loaded yet, but your article continues below.

Now that rent stabilization has passed both chambers, a deal on a reasonable cap must be struck.